Research progress of urethral cancer secondary to bladder cancer after radical cystectomy
-
摘要: 膀胱癌术后尿道复发在膀胱癌根治联合尿流改道术后总体发生率较低，但会严重影响患者的生活质量和生存周期。因此，提高尿道复发的认知对膀胱癌术后的管理和预后具有重要意义。本文就膀胱癌根治术后尿道复发的发生率、危险因素、诊疗方法和生存结果的研究进展进行综述。Abstract: The overall incidence of urethral recurrence after radical cystectomy combined with urinary diversion is low, but the quality of life and survival cycle of patients are seriously affected. Therefore, improving the awareness of urethral recurrence is of great significance for the management and prognosis of bladder cancer after surgery. This article reviews the incidence, risk factors, diagnosis and treatment methods and survival outcomes of urethral recurrence after radical cystectomy for bladder cancer.
-
Key words:
- bladder cancer /
- total cystectomy /
- recurrence /
- urethral carcinoma /
- progress
-
-
[1] Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review[J]. JAMA, 2020, 324(19): 1980-1991. doi: 10.1001/jama.2020.17598
[2] Xiang ZS, Ye ZJ, Ma JY, et al. Temporal trends and projections of bladder cancer burden in China from 1990 to 2030: findings from the global burden of disease study[J]. Clin Epidemiol, 2022, 14: 1305-1315. doi: 10.2147/CLEP.S387289
[3] Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines[J]. Eur Urol, 2021, 79(1): 82-104. doi: 10.1016/j.eururo.2020.03.055
[4] 刘苑, 周晓洲, 何鹏, 等. 机器人辅助下根治性膀胱切除全腹腔内与腹腔外回肠通道术后早期并发症研究[J]. 临床泌尿外科杂志, 2022, 37(11): 827-831. doi: 10.13201/j.issn.1001-1420.2022.11.005 https://lcmw.whuhzzs.com/article/doi/10.13201/j.issn.1001-1420.2022.11.005
[5] Gakis G, Black PC, Bochner BH, et al. Systematic review on the fate of the remnant urothelium after radical cystectomy[J]. Eur Urol, 2017, 71(4): 545-557. doi: 10.1016/j.eururo.2016.09.035
[6] Yao ZC, Jiang YZ, Zhu XQ, et al. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study[J]. Int J Clin Oncol, 2020, 25(7): 1377-1384. doi: 10.1007/s10147-020-01679-w
[7] Laukhtina E, Mori K, D Andrea D, et al. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: a systematic review and meta-analysis[J]. Urol Oncol, 2021, 39(12): 806-815. doi: 10.1016/j.urolonc.2021.06.009
[8] Laukhtina E, Moschini M, Soria F, et al. Follow-up of the urethra and management of urethral recurrence after radical cystectomy: a systematic review and proposal of management algorithm by the European association of urology-young academic urologists: urothelial carcinoma working group[J]. Eur Urol Focus, 2022, 8(6): 1635-1642. doi: 10.1016/j.euf.2022.03.004
[9] Hrbá ek J, Macek P, Ali-El-Dein B, et al. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases[J]. Urol Int, 2015, 94(1): 45-49. doi: 10.1159/000363112
[10] Chan Y, Fisher P, Tilki D, et al. Urethral recurrence after cystectomy: current preventative measures, diagnosis and management[J]. BJU Int, 2016, 117(4): 563-569. doi: 10.1111/bju.13370
[11] Li XY, Wang WW, Zhu GM, et al. Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients[J]. Oncotarget, 2018, 9(2): 2782-2796. doi: 10.18632/oncotarget.23451
[12] Fahmy O, Khairul-Asri MG, Schubert T, et al. Urethral recurrence after radical cystectomy for urothelial carcinoma: a systematic review and meta-analysis[J]. Urol Oncol, 2018, 36(2): 54-59. doi: 10.1016/j.urolonc.2017.11.007
[13] 沈思宏, 曾骁, 彭聊, 等. 原位新膀胱的尿流动力学评估及改善尿控功能的重建技术[J]. 临床泌尿外科杂志, 2023, 38(2): 146-150. doi: 10.13201/j.issn.1001-1420.2023.02.014 https://lcmw.whuhzzs.com/article/doi/10.13201/j.issn.1001-1420.2023.02.014
[14] 杨景添, 何旺, 黄健. 原位新膀胱术改善尿控相关解剖及手术技术[J]. 临床泌尿外科杂志, 2022, 37(11): 832-836. doi: 10.13201/j.issn.1001-1420.2022.11.006 https://lcmw.whuhzzs.com/article/doi/10.13201/j.issn.1001-1420.2022.11.006
[15] Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline[J]. J Urol, 2017, 198(3): 552-559. doi: 10.1016/j.juro.2017.04.086
[16] Balcı U, Dogantekin E, Özer K, et al. Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience[J]. Int J Surg, 2015, 13: 148-151. doi: 10.1016/j.ijsu.2014.12.006
[17] Horwich A, Babjuk M, Bellmunt J, et al. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees[J]. Ann Oncol, 2019, 30(11): 1697-1727. doi: 10.1093/annonc/mdz296
[18] Khanna A, Zganjar A, Lyon T, et al. A contemporary analysis of urethral recurrence following radical cystectomy[J]. J Urol, 2021, 206(4): 970-977. doi: 10.1097/JU.0000000000001842
[19] Laukhtina E, Boehm A, Peyronnet B, et al. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study[J]. World J Urol, 2022, 40(7): 1689-1696. doi: 10.1007/s00345-022-04025-z
[20] Lee DH, Song W. Risk factors for urethral recurrence in men after radical cystectomy with orthotopic urinary diversion for urothelial carcinoma: a retrospective cohort study[J]. Cancer Manag Res, 2020, 12: 6739-6746. doi: 10.2147/CMAR.S260979
[21] Stein JP, Penson DF, Wu SD, et al. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature[J]. J Urol, 2007, 178(3 Pt 1): 756-760.
[22] Laukhtina E, Rajwa P, Mori K, et al. Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic meta-analysis[J]. Eur Urol Focus, 2022, 8(3): 752-760. doi: 10.1016/j.euf.2021.05.010
[23] Devlin CM, Molokwu CN, Wood B, et al. Routine urethroscopic surveillance is of limited value after radical cystectomy: a single centre retrospective cohort analysis[J]. Int Urol Nephrol, 2022, 54(12): 3139-3144. doi: 10.1007/s11255-022-03312-3
[24] Boorjian SA, Kim SP, Weight CJ, et al. Risk factors and outcomes of urethral recurrence following radical cystectomy[J]. Eur Urol, 2011, 60(6): 1266-1272. doi: 10.1016/j.eururo.2011.08.030
[25] Boorjian SA, Tollefson MK, Cheville JC, et al. Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival[J]. J Urol, 2011, 186(5): 1796-1802. doi: 10.1016/j.juro.2011.07.005
[26] Pichler R, Tulchiner G, Oberaigner W, et al. Effect of urinary cytology for detecting recurrence in remnant urothelium after radical cystectomy: insights from a 10-year cytology database[J]. Clin Genitourin Cancer, 2017, 15(5): e783-e791. doi: 10.1016/j.clgc.2017.03.003
[27] Chen HY, Liu L, Pambuccian SE, et al. Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion[J]. Cancer Cytopathol, 2016, 124(4): 273-278. doi: 10.1002/cncy.21650
[28] Rodríguez-Serrano A, Carrión DM, Gómez Rivas J, et al. Prognostic value of urinary cytology for detecting urothelial carcinoma recurrence after radical cystectomy[J]. Actas Urol Esp, 2021, 45(6): 466-472. doi: 10.1016/j.acuro.2020.11.002
[29] Yamashita S, Hoshi S, Ohyama C, et al. Urethral recurrence following neobladder in bladder cancer patients[J]. Tohoku J Exp Med, 2003, 199(4): 197-203. doi: 10.1620/tjem.199.197
[30] Marcq G, Afferi L, Neuzillet Y, et al. Oncological outcomes for patients harboring positive surgical margins following radical cystectomy for muscle-invasive bladder cancer: a retrospective multicentric study on behalf of the YAU urothelial group[J]. Cancers, 2022, 14(23): 5740. doi: 10.3390/cancers14235740
[31] Nelles JL, Konety BR, Saigal C, et al. Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival[J]. J Urol, 2008, 180(5): 1933-1937. doi: 10.1016/j.juro.2008.07.039
[32] Hakozaki K, Kikuchi E, Ogihara K, et al. Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer[J]. Jpn J Clin Oncol, 2021, 51(2): 287-295. doi: 10.1093/jjco/hyaa168
[33] Mehrnoush V, Ismail A, Zakaria A, et al. Micropapillary bladder cancer: an added indication to prophylactic urethrectomy[J]. J Surg Case Rep, 2021, 2021(11): rjab501. doi: 10.1093/jscr/rjab501
[34] Nieder AM, Sved PD, Gomez P, et al. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring[J]. Urology, 2004, 64(5): 950-954. doi: 10.1016/j.urology.2004.06.012
[35] Zhou XZ, Ji HX, Zhang H, et al. Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer-practice in a single centre[J]. J Int Med Res, 2018, 46(9): 3928-3937. doi: 10.1177/0300060518782015
[36] Clark PE, Stein JP, Groshen SG, et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer[J]. J Urol, 2004, 172(4 Pt 1): 1342-1347.
[37] Varol C, Thalmann GN, Burkhard FC, et al. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution[J]. J Urol, 2004, 172(3): 937-942. doi: 10.1097/01.ju.0000135626.91587.c8
-
计量
- 文章访问数: 829
- PDF下载数: 168
- 施引文献: 0
下载: